HA
HAO.US Haoxi Health Technology Limited
- Market cap
- USD 1.33M
- P/E
- -
- P/B
- 0.04x
- ROE
- -106.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is HAO.US undervalued?
Graham numberThe Graham number of Haoxi Health Technology Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Haoxi Health Technology Limited fundamental analysis
No fundamental analysis for Haoxi Health Technology Limited yet.
Haoxi Health Technology Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Haoxi Health Technology Limited
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online sho…
Full company profileHaoxi Health Technology Limited financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Haoxi Health Technology Limited annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 12.8M | 16.2M | 28.2M | 48.5M | 48.5M | 32.8M | 110M |
| Gross Profit | 606K | 649K | 2.06M | 2.75M | 2.75M | 928K | 1.26M |
| Operating Income | 331K | 269K | 1.20M | 2.75M | 1.72M | -2.00M | -17.5M |
| EBITDA | 331K | 272K | 1.22M | 2.75M | 1.79M | 4.57M | -16.7M |
| Net Income | 304K | 245K | 970K | 1.29M | 1.29M | 3.88M | -19.1M |
| EPS | 0.61 | 0.49 | 1.76 | 0.04 | 2.11 | 32 | -773 |
| Balance Sheet | |||||||
| Total Assets | 2.81M | 543K | 4.46M | 15.5M | 15.5M | 21.6M | 21.6M |
| Total Liabilities | 4.74M | 2.01M | 2.90M | 4.23M | 4.23M | 4.22M | 3.71M |
| Shareholders' Equity | -1.93M | -1.47M | 1.57M | 11.3M | 11.3M | 17.4M | 17.9M |
| Cash & Short-term Investments | 55.9K | 294K | 1.20M | 6.66M | 6.66M | 8.62M | 10.9M |
| Total Debt | 335K | 505K | 850K | - | 1.20M | 1.99M | 1.61M |
| Cash Flow | |||||||
| Operating Cash Flow | 2.65M | -675K | -872K | -748K | -748K | -3.36M | -5.14M |
| Capital Expenditure | 3.26K | 8.70K | 45.5K | 55.4K | 55.4K | 2.00 | 8.00 |
| Free Cash Flow | 2.65M | -684K | -918K | -803K | -803K | -3.36M | -5.14M |
| Ratios | |||||||
| ROE | - | - | 61.9% | 11.4% | 11.5% | 22.3% | -106.8% |
| ROA | 10.8% | 45.0% | 21.7% | 8.3% | 8.3% | 18.0% | -88.4% |
| Net Profit Margin | 2.4% | 1.5% | 3.4% | 2.7% | 2.7% | 11.8% | -17.4% |
| Debt to Equity | - | - | 0.54x | - | 0.11x | 0.11x | 0.09x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Haoxi Health Technology Limited dividends
Haoxi Health Technology Limited has not paid dividends in the last 6 fiscal years.
Last stock split: 1:20 on Aug 14, 2026.
Who owns Haoxi Health Technology Limited
- Insiders 0.42%
- Institutions 0.61%
- Public & others 98.98%
- Shares outstanding 622K
- Free float 622K
Top institutions holding HAO.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Virtu Financial LLC | 11.6K | 0.16% | 0.00% | Jun 2026 |
| XTX Topco Ltd | 0.00 | 0.00% | -100.00% | Jun 2026 |
| UBS Group AG | 0.00 | 0.00% | -100.00% | Jun 2026 |
Haoxi Health Technology Limited company profile
- Company name
- Haoxi Health Technology Limited
- Ticker
- HAO.US
- ISIN
- KYG4290F1265
- Exchange
- USA Stocks
- Listed since
- Jan 30, 2008
- Sector
- Communication Services
- Industry
- Media
- Employees
- 28
- Fiscal year end
- December
- Address
- Tower C, Building 103, Chaoyang, China
- Phone
- 86 10 13311 587976
- Website
- haoximedia.com
About Haoxi Health Technology Limited
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Weibo. It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Haoxi Health Technology Limited management
3- Mr. Zhen FanChairman & CEO · born 1980
- Mr. Lei XuFounder, COO & Director · born 1989
- Ms. Dongxue LiChief Financial Officer · born 1988